Home Vivus - Flat Qsymia Scripts Point To Needed Shift
 

Keywords :   


Vivus - Flat Qsymia Scripts Point To Needed Shift

2015-03-02 21:52:57| Biotech - Topix.net

It is no secret that the Vivus's anti-obesity pill Qsymia have been pretty flat for over a year. If a flat sales trajectory is not troubling enough, the fact that Contrave from Orexigen is about to overtake Qsymia in just about 20 or 21 weeks should be a clear signal that a change is needed.

Tags: point needed flat shift

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
16.06Eastern North Pacific Tropical Weather Outlook
16.06Atlantic Tropical Weather Outlook
16.06Eastern North Pacific Tropical Weather Outlook
16.06Atlantic Tropical Weather Outlook
16.06Weekly Recap: U.S. House Approves WIPPES Legislation, Drylock Holds Private Label Academy & More
16.06Atlantic Tropical Weather Outlook
16.06Eastern North Pacific Tropical Weather Outlook
16.06Atlantic Tropical Weather Outlook
More »